Grufity logoGrufity logo
StocksFundsSearch FilingsAPI

Metlife Inc Stock Research

MET

66.09USD-0.27(-0.41%)Market Closed
Watchlist

Market Summary

USD66.09-0.27
Market Closed
-0.41%

MET Alerts

  • Big fall in earnings (Y/Y)

MET Stock Price

MET RSI Chart

MET Valuation

Market Cap

50.0B

Price/Earnings (Trailing)

22.49

Price/Sales (Trailing)

0.71

EV/EBITDA

9.17

Price/Free Cashflow

4.23

MET Price/Sales (Trailing)

MET Profitability

EBT Margin

3.45%

Return on Equity

6.06%

Return on Assets

0.29%

Free Cashflow Yield

23.65%

MET Fundamentals

MET Revenue

Revenue (TTM)

70.6B

Revenue Y/Y

7.43%

Revenue Q/Q

8.03%

MET Earnings

Earnings (TTM)

2.2B

Earnings Y/Y

-55.82%

Earnings Q/Q

372.94%

Price Action

52 Week Range

48.9577.36
(Low)(High)

Last 7 days

3.6%

Last 30 days

6.7%

Last 90 days

22.7%

Trailing 12 Months

1.6%

MET Financial Health

MET Investor Care

Dividend Yield

3.07%

Dividend/Share (TTM)

2.03

Buy Backs (1Y)

5.06%

Diluted EPS (TTM)

2.54

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales

Latest Insider Trading transactions for MET

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-09-14
Herzog David L
acquired
3,032
65.93
46.00
-
2023-09-14
GRISE CHERYL W
acquired
39,096
65.93
593
-
2023-09-14
KELLY EDWARD J III
acquired
16,086
65.93
244
-
2023-09-14
Johnson Jeh C.
acquired
923
65.93
14.00
-
2023-09-14
MCKENZIE DIANA
acquired
8,439
65.93
128
-
2023-09-14
HASSELL GERALD L
acquired
9,823
65.93
149
-
2023-09-14
Kinney Catherine R
acquired
18,658
65.93
283
-
2023-09-14
HUBBARD ROBERT GLENN
acquired
41,272
65.93
626
-
2023-09-14
Kennard William E
acquired
18,987
65.93
288
-
2023-08-31
TADROS RAMY
acquired
-
-
7,894
president, u.s. business

1–10 of 50

Which funds bought or sold MET recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-09-19
BIRMINGHAM CAPITAL MANAGEMENT CO INC/AL
reduced
-17.19
-420,757
1,769,950
0.74%
2023-09-13
CGC Financial Services, LLC
new
-
6,444
6,444
-%
2023-09-12
Farther Finance Advisors, LLC
reduced
-9.98
-9,091
65,739
0.01%
2023-09-08
TUCKER ASSET MANAGEMENT LLC
unchanged
-
-826
33,127
0.01%
2023-09-07
ST GERMAIN D J CO INC
new
-
92,822
92,822
-%
2023-09-01
Portside Wealth Group, LLC
new
-
735,817
735,817
0.14%
2023-08-29
Garde Capital, Inc.
new
-
460,000
460,000
0.04%
2023-08-24
Alberta Investment Management Corp
unchanged
-
-58,374
2,340,340
0.02%
2023-08-23
Rehmann Capital Advisory Group
reduced
-4.6
-57,996
780,357
0.07%
2023-08-23
Stonebridge Capital Advisors LLC
added
26.09
7,887
42,323
-%

1–10 of 48

Latest Funds Activity

Are funds buying MET calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own MET
No. of Funds

Schedule 13G FIlings of Metlife

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Aug 04, 2023
board of directors of metlife inc
16.0%
120,043,226
SC 13D/A
May 04, 2023
board of directors of metlife inc
15.9%
121,521,424
SC 13D/A
Feb 23, 2023
board of directors of metlife inc
15.9%
122,923,807
SC 13D/A
Feb 14, 2023
dodge & cox
6.8%
53,583,210
SC 13G/A
Feb 09, 2023
vanguard group inc
7.08%
55,519,588
SC 13G/A
Jan 31, 2023
blackrock inc.
7.1%
55,514,415
SC 13G/A
May 05, 2022
board of directors of metlife inc
15.6%
127,128,424
SC 13D/A
Feb 14, 2022
dodge & cox
7.0%
58,725,183
SC 13G/A
Feb 09, 2022
vanguard group inc
6.77%
56,951,725
SC 13G/A
Feb 03, 2022
blackrock inc.
8.5%
71,686,373
SC 13G/A

Recent SEC filings of Metlife

View All Filings
Date Filed Form Type Document
Sep 18, 2023
4
Insider Trading
Sep 18, 2023
4
Insider Trading
Sep 18, 2023
4
Insider Trading
Sep 18, 2023
4
Insider Trading
Sep 18, 2023
4
Insider Trading
Sep 18, 2023
4
Insider Trading
Sep 18, 2023
4
Insider Trading
Sep 18, 2023
4
Insider Trading
Sep 18, 2023
4
Insider Trading
Sep 05, 2023
4
Insider Trading

Peers (Alternatives to Metlife)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
50.0B
70.6B
6.68% 1.60%
22.49
0.71
4.01% -58.32%
38.7B
64.4B
8.46% 7.56%
125.56
0.61
4.97% -6.22%
38.7B
38.7B
4.54% 6.04%
17.31
1
8.33% -37.32%
25.2B
13.3B
0.67% 24.34%
20.79
1.9
12.64% 55.58%
11.7B
5.3B
-1.65% 6.99%
17.51
2.22
1.78% -46.10%
-
22.8B
- -
-
-
34.59% 179.04%
MID-CAP
7.2B
2.7B
-0.13% 55.74%
15.98
2.64
-1.39% 16.12%
4.4B
15.3B
0.50% -43.85%
-3.31
0.29
-26.53% -139.84%
4.2B
2.7B
2.00% 43.46%
3.53
1.58
38.34% -32.53%
3.4B
1.9B
7.96% 5.39%
2.13
1.8
-77.15% -71.29%
2.7B
7.5B
3.00% 49.36%
5.07
0.36
-1.40% -38.58%
SMALL-CAP
81.1M
171.0M
-2.50% -17.43%
-6.56
0.47
-0.92% 29.17%
39.9M
187.0M
2.62% -36.73%
60.43
0.21
-4.23% -77.34%

Metlife News

MarketBeat
SG Americas Securities LLC Reduces Stake in MetLife, Inc. (NYSE ....
MarketBeat,
56 minutes ago
StreetInsider.com
Form 253G2 Rise Companies Corp.
StreetInsider.com,
19 hours ago
Marketscreener.com

Returns for MET

Cumulative Returns on MET

7.8%


10-Year Cumulative Returns

10.9%


7-Year Cumulative Returns

9.6%


5-Year Cumulative Returns

21.5%


3-Year Cumulative Returns

Risks for MET

What is the probability of a big loss on MET?

49.2%


Probability that Metlife stock will be more than 20% underwater in next one year

27.3%


Probability that Metlife stock will be more than 30% underwater in next one year.

18.9%


Probability that Metlife stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does MET drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Metlife was unfortunately bought at previous high price.

Drawdowns

Financials for Metlife

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Last 12 Months)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Revenue1.7%70,59769,44869,89873,23867,87370,92371,08070,40969,51965,09467,84265,56768,23071,62869,62068,13965,75069,43867,94168,11968,001
Operating Expenses1.9%12,12111,89612,03411,85412,41512,38812,58612,73912,92513,02713,15013,35713,33013,73713,68913,45313,47913,57413,71414,07113,920
EBITDA-100.0%-3,3393,7643,3374,9709,4619,0407,9026,7702,4837,8187,3149,16611,3387,451------
EBITDA Margin-100.0%-0.05*0.05*0.05*0.07*0.13*0.13*0.11*0.10*0.04*0.12*0.11*0.13*0.16*0.11*------
Interest Expenses0.4%9429389058999099119149189059088918968809529649681,0481,0351,1301,1211,205
Earnings Before Taxes-16.5%2,8333,3912,8594,6486,2719,7708,1266,9845,8651,5756,9276,7268,59410,6946,7959,3037,5916,3956,3074,7974,203
EBT Margin-100.0%-0.03*0.04*0.03*0.06*0.12*0.11*0.10*0.08*0.02*0.10*0.10*0.13*0.15*0.10*------
Net Income-18.6%2,2252,7332,5394,1495,3387,8356,5545,5124,6341,3725,4105,8457,3238,9195,8997,3736,1015,2515,1235,3734,370
Net Income Margin-100.0%-0.03*0.04*0.03*0.05*0.10*0.09*0.08*0.07*0.02*0.08*0.09*0.11*0.12*0.08*------
Free Cashflow-100.0%-13,19013,20416,01015,23813,05412,59612,40912,69611,28811,63911,66712,02013,56113,786------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Assets0.4%677,279674,266663,072650,104662,893724,284759,708761,664773,253769,814795,146780,492767,583737,741740,463742,812732,167713,188687,538698,451706,333
    Cash Equivalents-16.5%15,41718,45620,19522,20020,54823,48820,04718,95625,03719,63519,79524,40524,28924,09416,59819,45218,43514,50615,82112,49016,312
  Goodwill-1.3%9,2619,3799,2979,0059,1519,5109,5359,6389,7689,94410,1129,3609,2459,1599,3089,2789,4089,4189,4229,4409,499
Liabilities0.8%646,787641,843632,947624,774625,526670,047691,959692,331703,830703,677720,329706,923691,643667,278674,081674,193668,121654,450634,580646,642652,501
  Short Term Borrowings19.0%200168175183196323341346393302393351303298235142158289268290479
Shareholder's Equity-6.7%30,26132,42329,88125,07634,00942,70350,01369,33369,42366,13774,81773,56975,94070,46366,38268,61964,04658,73852,95851,80953,832
  Retained Earnings-0.1%39,92839,95740,33241,03241,10141,40641,19740,42639,31836,37331,82436,78236,56836,91933,07832,94831,20929,94428,92627,33126,870
  Additional Paid-In Capital0.0%33,63033,61733,61633,58933,54833,53133,51133,45733,44033,91033,81233,74433,72833,71132,68032,63932,60232,53532,47432,47532,454
Shares Outstanding-1.6%7577697797877988158268458618788939069089089159209369509599871,000
Minority Interest0.9%231229244254266272267283285273259253247242238251235229217184199
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Cashflow From Operations-10.3%11,83513,19013,20416,01015,27913,14012,59612,40912,69611,28811,63911,66712,02013,56113,7869,9069,29312,51411,73812,48713,688
Cashflow From Investing-228.8%-12,159-3,698-2,620-5,285-9,453-10,559-11,187-10,487-8,886-11,286-18,569-23,500-22,172-20,224-17,586-5,135-6,012-10,848-5,634-10,710-14,491
Cashflow From Financing66.4%-4,801-14,268-10,108-6,742-9,6661,054-1,375-7,033-3,040-3,99210,72916,71316,15516,4094,5682,245-1,163-703-2,801-2,064-100
  Dividend Payments-0.6%1,5811,5901,5981,6101,6231,6361,6471,6571,6631,6611,6571,6481,6421,6421,6431,6521,6581,6671,6781,6851,693
  Buy Backs-14.0%2,7223,1663,3263,9064,2474,2444,3033,6982,7631,6501,1518301,5352,2852,2853,2353,0863,4513,9923,4143,273

MET Income Statement

2023-06-30
Consolidated Statements of Operations and Comprehensive Income (Unaudited) - USD ($)
$ in Millions
3 Months Ended6 Months Ended
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Revenues      
Premiums$ 11,678 $ 11,556 $ 21,267$ 22,173
Universal life and investment-type product policy fees1,288 1,372 2,5772,684
Net investment income5,072 3,583 9,7177,867
Other revenues621 615 1,2601,275
Net investment gains (losses)(1,039) (682) (1,723)(1,199)
Net derivative gains (losses)(997) (970) (1,087)(1,921)
Total revenues16,623 15,474 32,01130,879
Expenses      
Policyholder benefits and claims11,809 11,615 21,68122,789
Policyholder liability remeasurement (gains) losses(16) (1) (25)(42)
Market risk benefit remeasurement (gains) losses(817) (757) (629)(2,197)
Interest credited to policyholder account balances1,933 527 3,7971,153
Policyholder dividends151 194 310393
Other expenses3,133 2,908 6,1905,860
Total expenses16,193 14,486 31,32427,956
Income (loss) before provision for income tax430 988 6872,923
Provision for income tax expense (benefit)22 73 194369
Net income (loss)408$ 85915$ 1,6394932,554
Less: Net income (loss) attributable to noncontrolling interests6 5 1110
Net income (loss) attributable to MetLife, Inc.402 910 4822,544
Less: Preferred stock dividends32$ 6629$ 639892
Net income (loss) available to MetLife, Inc.’s common shareholders370 881 3842,452
Comprehensive income (loss)(829) (7,148) 2,712(13,104)
Less: Comprehensive income (loss) attributable to noncontrolling interests, net of income tax8 4 (5)7
Comprehensive income (loss) attributable to MetLife, Inc.$ (837) $ (7,152) $ 2,717$ (13,111)
Net income (loss) available to MetLife, Inc.’s common shareholders per common share:      
Basic$ 0.48 $ 1.09 $ 0.50$ 3.00
Diluted$ 0.48 $ 1.08 $ 0.50$ 2.98

MET Balance Sheet

2023-06-30
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Investments:  
Fixed maturity securities available-for-sale, at estimated fair value (net of allowance for credit loss of $197 and $183, respectively); and amortized cost: $307,045 and $306,025, respectively$ 283,857$ 276,780
Equity securities7691,684
Contractholder-directed equity securities and fair value option securities, at estimated fair value10,2049,668
Mortgage loans (net of allowance for credit loss of $724 and $527, respectively)92,98683,763
Policy loans8,7888,874
Real estate and real estate joint ventures (includes $310 and $299, respectively, under the fair value option)13,04513,137
Other limited partnership interests14,72214,414
Short-term investments, principally at estimated fair value6,9214,935
Other invested assets (net of allowance for credit loss of $21 and $26, respectively; includes $2,088 and $1,926, respectively, of leveraged and direct financing leases; $338 and $326, respectively, relating to variable interest entities)19,65620,038
Total investments450,948433,293
Cash and cash equivalents, principally at estimated fair value15,41720,195
Accrued investment income3,5053,446
Premiums, reinsurance and other receivables18,53017,364
Market risk benefits279280
Deferred policy acquisition costs and value of business acquired19,85019,653
Current income tax recoverable18942
Deferred income tax asset2,3772,439
Goodwill9,2619,297
Other assets10,97711,025
Separate account assets145,946146,038
Total assets677,279663,072
Liabilities  
Future policy benefits190,474187,222
Policyholder account balances214,413210,597
Market risk benefits3,2593,763
Other policy-related balances19,64218,424
Policyholder dividends payable366387
Payables for collateral under securities loaned and other transactions18,80620,937
Short-term debt200175
Long-term debt14,53914,647
Collateral financing arrangement675716
Junior subordinated debt securities3,1603,158
Deferred income tax liability752950
Other liabilities34,55525,933
Separate account liabilities145,946146,038
Total liabilities646,787632,947
Contingencies, Commitments and Guarantees (Note 18)
MetLife, Inc.’s stockholders’ equity:  
Preferred stock, par value $0.01 per share; $3,905 aggregate liquidation preference00
Common stock, par value $0.01 per share; 3,000,000,000 shares authorized; 1,191,608,802 and 1,189,831,471 shares issued, respectively; 757,210,115 and 779,098,414 shares outstanding, respectively1212
Additional paid-in capital33,63033,616
Retained earnings39,92840,332
Treasury stock, at cost; 434,398,687 and 410,733,057 shares, respectively(22,923)(21,458)
Accumulated other comprehensive income (loss)(20,386)(22,621)
Total MetLife, Inc.’s stockholders’ equity30,26129,881
Noncontrolling interests231244
Total equity30,49230,125
Total liabilities and equity$ 677,279$ 663,072

About Metlife